Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers

Neoadjuvant chemotherapy for resectable colorectal liver metastases: What is the evidence? Results of a systematic review of comparative studies

(2015) Giuseppe Nigri et al.   SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND

Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival

(2014) Masayuki Okuno et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases

(2014) Dexiang Zhu et al.   PLoS One

Comparison Between Perioperative and Postoperative Chemotherapy After Potentially Curative Hepatic Resection for Metastatic Colorectal Cancer

(2013) Raphael Araujo et al.   ANNALS OF SURGICAL ONCOLOGY

Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis

(2013) H.S.C. Ribeiro et al.   EJSO

Risk Stratification of 7,732 Hepatectomy Cases in 2011 from the National Clinical Database for Japan

(2013) Akira Kenjo et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

(2013) Bernard Nordlinger et al.   LANCET ONCOLOGY

Peri-operative chemotherapy for resectable colorectal liver metastasis: Does timing of systemic therapy matter?

(2011) Hugo Pinto Marques et al.   JOURNAL OF SURGICAL ONCOLOGY

Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?

(2011) Srinevas K. Reddy et al.   JOURNAL OF SURGICAL ONCOLOGY

Safety of hepatic resection for colorectal metastases in the era of neo-adjuvant chemotherapy

(2011) Alessandro Cucchetti et al.   LANGENBECKS ARCHIVES OF SURGERY

Influence of Preoperative Chemotherapy on the Intraoperative and Postoperative Course of Liver Resection for Colorectal Cancer Metastases

(2011) Lidewij Spelt et al.   WORLD JOURNAL OF SURGERY

Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?

(2010) Rene Adam et al.   ANNALS OF SURGERY

Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy

(2009) Hiroshi Nakano et al.   ANNALS OF SURGERY

Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver

(2009) J. M. Cleary et al.   ONCOLOGIST

Safety and Efficacy of Modified FOLFOX6 for Treatment of Metastatic or Locally Advanced Colorectal Cancer

(2008) Shigemi Matsumoto et al.   CHEMOTHERAPY

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

(2008) Emmanuel Mitry et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET